Articles

Advancing the Atlas

Multi-center team details the expression of genes in numerous cell types involved in immunity
Written byKelsey Kaustinen
| 3 min read

STOCKHOLM—The Human Genome Project was a massive, international undertaking to sequence the entirety of the human genome, and one that revolutionized the collective understanding of human genetics. The scope of the work—and the data it generated—led to countless discoveries, and has inspired similar mapping efforts since then.

In a similar vein, the latest database released by the Swedish-based Human Protein Atlas program is the Blood Atlas, which provides a directory of human immune cells and their respective proteins. Led by Mathias Uhlén, professor at the Department of Protein Science at KTH Royal Institute of Technology and visiting professor at the Department of Neuroscience at Karolinska Institutet, the open-access database provides a wealth of information about the immune system and the genes and proteins associated with immune cells.

To continue reading this article, subscribe for FREE toDrug Discovery News Logo

Subscribe today to keep up to date with the latest advancements and discoveries in drug development achieved by scientists in pharma, biotech, non-profit, academic, clinical, and government labs.

Add Drug Discovery News as a preferred source on Google

Add Drug Discovery News as a preferred Google source to see more of our trusted coverage.

About the Author

Here are some related topics that may interest you:

Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
Illustration of multiple three-dimensional patient-derived organoids suspended against a dark blue background, representing tumor models used in precision oncology research.
By combining organoid biology with precision automation, researchers developed a miniaturized organoid screening platform that could help speed personalized cancer treatment testing.
3D illustration of a membrane protein embedded within a lipid nanodisc, representing a native-like environment used for membrane protein stabilization and characterization.
Mass photometry supports membrane protein characterization by providing rapid insights into sample composition, purity, and molecular assembly.
Drug Discovery News December 2025 Issue
Latest IssueVolume 21 • Issue 4 • December 2025

December 2025

December 2025 Issue

Explore this issue